PriceTargets.com logo

ClearPoint Neuro - CLPT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.33
  • Forecasted Upside: -27.21%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$15.57 As of 12/30/2024 12:57 PM ET
▼ -0.18 (-1.14%)

This chart shows the closing price for CLPT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ClearPoint Neuro Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLPT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLPT

Analyst Price Target is $11.33
▼ -27.21% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for ClearPoint Neuro in the last 3 months. The average price target is $11.33, with a high forecast of $15.00 and a low forecast of $9.00. The average price target represents a -27.21% upside from the last price of $15.57.

This chart shows the closing price for CLPT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in ClearPoint Neuro. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/9/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/7/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/5/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/4/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/3/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/1/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/30/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/27/2024Lake Street CapitalBoost TargetBuy ➝ Buy$11.00 ➝ $15.00
7/25/2024B. RileyInitiated CoverageBuy$10.00
3/13/2024Stifel NicolausReiterated RatingBuy ➝ Buy$8.00 ➝ $9.00
12/1/2023B. RileyReiterated RatingBuy
10/24/2023Stifel NicolausInitiated CoverageBuy$8.00
8/9/2023Lake Street CapitalLower TargetBuy ➝ Buy$22.00 ➝ $15.00
2/16/2023B. RileyReiterated RatingBuy$14.00
5/9/2022B. RileyReiterated RatingBuy
4/5/2022B. RileyInitiated CoverageBuy$15.00
8/11/2021B. RileyReiterated RatingBuy
3/18/2021Lake Street CapitalInitiated CoverageBuy$32.00
2/22/2021B. RileyReiterated RatingBuy$23.00 ➝ $38.00
1/28/2021B. RileyReiterated RatingBuy$8.00
1/22/2021B. RileyBoost TargetBuy$18.00 ➝ $23.00
1/12/2021B. RileyBoost TargetBuy$16.00 ➝ $18.00
11/11/2020B. RileyBoost Target$8.00 ➝ $10.50
7/17/2020B. RileyInitiated CoverageBuy$8.00
3/12/2020Brookline Capital ManagementInitiated CoverageBuy$15.00
3/11/2020Brookline Capital ManagementReiterated RatingBuy
(Data available from 12/30/2019 forward)

News Sentiment Rating

0.75 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/3/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/3/2024
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/2/2024
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/1/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2024
  • 6 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2024
  • 4 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2024

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

ClearPoint Neuro logo
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Read More

Today's Range

Now: $15.57
Low: $15.15
High: $15.61

50 Day Range

MA: $13.25
Low: $10.74
High: $16.68

52 Week Range

Now: $15.57
Low: $5.11
High: $17.47

Volume

67,361 shs

Average Volume

191,980 shs

Market Capitalization

$429.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Frequently Asked Questions

What sell-side analysts currently cover shares of ClearPoint Neuro?

The following sell-side analysts have issued reports on ClearPoint Neuro in the last twelve months: B. Riley, Lake Street Capital, and Stifel Nicolaus.
View the latest analyst ratings for CLPT.

What is the current price target for ClearPoint Neuro?

0 Wall Street analysts have set twelve-month price targets for ClearPoint Neuro in the last year. Their average twelve-month price target is $11.33, suggesting a possible downside of 27.2%. Lake Street Capital has the highest price target set, predicting CLPT will reach $15.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $9.00 for ClearPoint Neuro in the next year.
View the latest price targets for CLPT.

What is the current consensus analyst rating for ClearPoint Neuro?

ClearPoint Neuro currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CLPT will outperform the market and that investors should add to their positions of ClearPoint Neuro.
View the latest ratings for CLPT.

What other companies compete with ClearPoint Neuro?

Other companies that are similar to ClearPoint Neuro include InMode, RxSight, MiMedx Group, BioLife Solutions and Embecta. Learn More about companies similar to ClearPoint Neuro.

How do I contact ClearPoint Neuro's investor relations team?

ClearPoint Neuro's physical mailing address is 5 MUSICK, IRVINE CA, 92618. The company's listed phone number is (949) 900-6833 and its investor relations email address is [email protected]. The official website for ClearPoint Neuro is www.clearpointneuro.com. Learn More about contacing ClearPoint Neuro investor relations.